Asia Business News | Saturday, August 30, 2008
RSS 2.0  
PANBIO LIMITED ASX: PBO - Market Update - Mr Paul Nitz, CEO/MD



About PANBIO LIMITED

PanBio Limited (ASX: PBO) develops, commercialises and markets a range of medical diagnostic kits used by hospitals, pathology laboratories, general practitioners and research institutions to test for infectious diseases. PBO has more than 60 diagnostic tests for more than 27 infectious diseases including Dengue fever, Ross River fever, glandular fever and whooping cough. As at 30 June 2004, the company supported over 120 clinical laboratories in Australia, Asia, the Americas, Europe, the Middle East and Africa.

About Boardroomradio

Sydney-based Boardroomradio (BRR) is an Investor Relations multi-media portal delivering audio webcasts to the investment community, including brokers, fund managers, analysts, and private investors.



 
   PANBIO LIMITED  
   BOARDROOMRADIO  
   ABN NEWSWIRE